Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Whooping Cough 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Solid Tumor 1Pneumococcal Infections 1Neoplasm Metastasis 1Measles 1Hepatitis B 1HIV Infections 1Condylomata Acuminata 1

Interventions

Colposcopy 9Imiquimod 7Conization 7Papillomavirus Vaccines 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Cryotherapy 6human papillomavirus vaccine, L1 type 16, 18 4Blood Specimen Collection 4Vaginal Smears 3Vaccines 3Papanicolaou Test 3VGX-3100 2Topotecan 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Human Papillomavirus DNA Tests 2Fluorouracil 2Cisplatin 2Biopsy 2Acetic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1methyl 5-aminolevulinate 1lime 1human papillomavirus vaccine, TA 1hecolin 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Dysplasia × Hepatitis B Vaccines × Clear all
NCT01356823 2016-01-05

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Xiamen University

Phase 2 Completed
1,600 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡